C-D-PAP
General Information
DRACP ID DRACP02357
Peptide Name C-D-PAP
Sequence Cklaklakklaklak
Sequence Length 15
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HepG2 | Hepatoblastoma | Blastoma | LD50>256 µg/ml; 32% Killing=250 µg/ml | CCK-8 assay | 48 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification k=D-Lys; l=D-Leu; a=D-Ala
Chiral Mix
Physicochemical Information
Formula C3H-21NO-12S
Absent amino acids ADEFGHIKLMNPQRSTVWY
Common amino acids C
Mass 11882
Pl 5.92
Basic residues 0
Acidic residues 0
Hydrophobic residues 0
Net charge 0
Boman Index 128
Hydrophobicity 16.67
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 33335804
Title Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [D(KLAKLAK)2] increases antimicrobial activities against multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli
Doi 2020
Year
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available